Global Radioactive Diagnostic Drugs Market 2024 by Company, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Radioactive Diagnostic Drugs market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
The Global Info Research report includes an overview of the development of the Radioactive Diagnostic Drugs industry chain, the market status of Oncology (Single Photon Drugs, Positron Drugs), Cardiology (Single Photon Drugs, Positron Drugs), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Radioactive Diagnostic Drugs.
Regionally, the report analyzes the Radioactive Diagnostic Drugs markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Radioactive Diagnostic Drugs market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Radioactive Diagnostic Drugs market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Radioactive Diagnostic Drugs industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Single Photon Drugs, Positron Drugs).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Radioactive Diagnostic Drugs market.
Regional Analysis: The report involves examining the Radioactive Diagnostic Drugs market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Radioactive Diagnostic Drugs market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Radioactive Diagnostic Drugs:
Company Analysis: Report covers individual Radioactive Diagnostic Drugs players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Radioactive Diagnostic Drugs This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Oncology, Cardiology).
Technology Analysis: Report covers specific technologies relevant to Radioactive Diagnostic Drugs. It assesses the current state, advancements, and potential future developments in Radioactive Diagnostic Drugs areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Radioactive Diagnostic Drugs market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Radioactive Diagnostic Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Chapter 1, to describe Radioactive Diagnostic Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Radioactive Diagnostic Drugs, with revenue, gross margin and global market share of Radioactive Diagnostic Drugs from 2019 to 2024.
Chapter 3, the Radioactive Diagnostic Drugs competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Radioactive Diagnostic Drugs market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Radioactive Diagnostic Drugs.
Chapter 13, to describe Radioactive Diagnostic Drugs research findings and conclusion.
The Global Info Research report includes an overview of the development of the Radioactive Diagnostic Drugs industry chain, the market status of Oncology (Single Photon Drugs, Positron Drugs), Cardiology (Single Photon Drugs, Positron Drugs), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Radioactive Diagnostic Drugs.
Regionally, the report analyzes the Radioactive Diagnostic Drugs markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Radioactive Diagnostic Drugs market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Radioactive Diagnostic Drugs market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Radioactive Diagnostic Drugs industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Single Photon Drugs, Positron Drugs).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Radioactive Diagnostic Drugs market.
Regional Analysis: The report involves examining the Radioactive Diagnostic Drugs market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Radioactive Diagnostic Drugs market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Radioactive Diagnostic Drugs:
Company Analysis: Report covers individual Radioactive Diagnostic Drugs players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Radioactive Diagnostic Drugs This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Oncology, Cardiology).
Technology Analysis: Report covers specific technologies relevant to Radioactive Diagnostic Drugs. It assesses the current state, advancements, and potential future developments in Radioactive Diagnostic Drugs areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Radioactive Diagnostic Drugs market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Radioactive Diagnostic Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
- Single Photon Drugs
- Positron Drugs
- Blood Perfusion Drugs
- Metabolizing Drugs
- Receptor Binding Drugs
- Others
- Oncology
- Cardiology
- Neuroscience
- Thyroid
- Others
- Curium
- Medi-Radiopharma
- Jubilant Radiopharma
- Telix
- Mallinckrodt
- Cardinal Health
- Bayer AG
- GE Healthcare
- Mallinckrodt Pharmaceuticals
- Bracco Group
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Radioactive Diagnostic Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Radioactive Diagnostic Drugs, with revenue, gross margin and global market share of Radioactive Diagnostic Drugs from 2019 to 2024.
Chapter 3, the Radioactive Diagnostic Drugs competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Radioactive Diagnostic Drugs market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Radioactive Diagnostic Drugs.
Chapter 13, to describe Radioactive Diagnostic Drugs research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Radioactive Diagnostic Drugs
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Radioactive Diagnostic Drugs by Type
1.3.1 Overview: Global Radioactive Diagnostic Drugs Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Radioactive Diagnostic Drugs Consumption Value Market Share by Type in 2023
1.3.3 Single Photon Drugs
1.3.4 Positron Drugs
1.3.5 Blood Perfusion Drugs
1.3.6 Metabolizing Drugs
1.3.7 Receptor Binding Drugs
1.3.8 Others
1.4 Global Radioactive Diagnostic Drugs Market by Application
1.4.1 Overview: Global Radioactive Diagnostic Drugs Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Oncology
1.4.3 Cardiology
1.4.4 Neuroscience
1.4.5 Thyroid
1.4.6 Others
1.5 Global Radioactive Diagnostic Drugs Market Size & Forecast
1.6 Global Radioactive Diagnostic Drugs Market Size and Forecast by Region
1.6.1 Global Radioactive Diagnostic Drugs Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Radioactive Diagnostic Drugs Market Size by Region, (2019-2030)
1.6.3 North America Radioactive Diagnostic Drugs Market Size and Prospect (2019-2030)
1.6.4 Europe Radioactive Diagnostic Drugs Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Radioactive Diagnostic Drugs Market Size and Prospect (2019-2030)
1.6.6 South America Radioactive Diagnostic Drugs Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Radioactive Diagnostic Drugs Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Curium
2.1.1 Curium Details
2.1.2 Curium Major Business
2.1.3 Curium Radioactive Diagnostic Drugs Product and Solutions
2.1.4 Curium Radioactive Diagnostic Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Curium Recent Developments and Future Plans
2.2 Medi-Radiopharma
2.2.1 Medi-Radiopharma Details
2.2.2 Medi-Radiopharma Major Business
2.2.3 Medi-Radiopharma Radioactive Diagnostic Drugs Product and Solutions
2.2.4 Medi-Radiopharma Radioactive Diagnostic Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Medi-Radiopharma Recent Developments and Future Plans
2.3 Jubilant Radiopharma
2.3.1 Jubilant Radiopharma Details
2.3.2 Jubilant Radiopharma Major Business
2.3.3 Jubilant Radiopharma Radioactive Diagnostic Drugs Product and Solutions
2.3.4 Jubilant Radiopharma Radioactive Diagnostic Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Jubilant Radiopharma Recent Developments and Future Plans
2.4 Telix
2.4.1 Telix Details
2.4.2 Telix Major Business
2.4.3 Telix Radioactive Diagnostic Drugs Product and Solutions
2.4.4 Telix Radioactive Diagnostic Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Telix Recent Developments and Future Plans
2.5 Mallinckrodt
2.5.1 Mallinckrodt Details
2.5.2 Mallinckrodt Major Business
2.5.3 Mallinckrodt Radioactive Diagnostic Drugs Product and Solutions
2.5.4 Mallinckrodt Radioactive Diagnostic Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Mallinckrodt Recent Developments and Future Plans
2.6 Cardinal Health
2.6.1 Cardinal Health Details
2.6.2 Cardinal Health Major Business
2.6.3 Cardinal Health Radioactive Diagnostic Drugs Product and Solutions
2.6.4 Cardinal Health Radioactive Diagnostic Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Cardinal Health Recent Developments and Future Plans
2.7 Bayer AG
2.7.1 Bayer AG Details
2.7.2 Bayer AG Major Business
2.7.3 Bayer AG Radioactive Diagnostic Drugs Product and Solutions
2.7.4 Bayer AG Radioactive Diagnostic Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Bayer AG Recent Developments and Future Plans
2.8 GE Healthcare
2.8.1 GE Healthcare Details
2.8.2 GE Healthcare Major Business
2.8.3 GE Healthcare Radioactive Diagnostic Drugs Product and Solutions
2.8.4 GE Healthcare Radioactive Diagnostic Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 GE Healthcare Recent Developments and Future Plans
2.9 Mallinckrodt Pharmaceuticals
2.9.1 Mallinckrodt Pharmaceuticals Details
2.9.2 Mallinckrodt Pharmaceuticals Major Business
2.9.3 Mallinckrodt Pharmaceuticals Radioactive Diagnostic Drugs Product and Solutions
2.9.4 Mallinckrodt Pharmaceuticals Radioactive Diagnostic Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Mallinckrodt Pharmaceuticals Recent Developments and Future Plans
2.10 Bracco Group
2.10.1 Bracco Group Details
2.10.2 Bracco Group Major Business
2.10.3 Bracco Group Radioactive Diagnostic Drugs Product and Solutions
2.10.4 Bracco Group Radioactive Diagnostic Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Bracco Group Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Radioactive Diagnostic Drugs Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Radioactive Diagnostic Drugs by Company Revenue
3.2.2 Top 3 Radioactive Diagnostic Drugs Players Market Share in 2023
3.2.3 Top 6 Radioactive Diagnostic Drugs Players Market Share in 2023
3.3 Radioactive Diagnostic Drugs Market: Overall Company Footprint Analysis
3.3.1 Radioactive Diagnostic Drugs Market: Region Footprint
3.3.2 Radioactive Diagnostic Drugs Market: Company Product Type Footprint
3.3.3 Radioactive Diagnostic Drugs Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Radioactive Diagnostic Drugs Consumption Value and Market Share by Type (2019-2024)
4.2 Global Radioactive Diagnostic Drugs Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Radioactive Diagnostic Drugs Consumption Value Market Share by Application (2019-2024)
5.2 Global Radioactive Diagnostic Drugs Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Radioactive Diagnostic Drugs Consumption Value by Type (2019-2030)
6.2 North America Radioactive Diagnostic Drugs Consumption Value by Application (2019-2030)
6.3 North America Radioactive Diagnostic Drugs Market Size by Country
6.3.1 North America Radioactive Diagnostic Drugs Consumption Value by Country (2019-2030)
6.3.2 United States Radioactive Diagnostic Drugs Market Size and Forecast (2019-2030)
6.3.3 Canada Radioactive Diagnostic Drugs Market Size and Forecast (2019-2030)
6.3.4 Mexico Radioactive Diagnostic Drugs Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Radioactive Diagnostic Drugs Consumption Value by Type (2019-2030)
7.2 Europe Radioactive Diagnostic Drugs Consumption Value by Application (2019-2030)
7.3 Europe Radioactive Diagnostic Drugs Market Size by Country
7.3.1 Europe Radioactive Diagnostic Drugs Consumption Value by Country (2019-2030)
7.3.2 Germany Radioactive Diagnostic Drugs Market Size and Forecast (2019-2030)
7.3.3 France Radioactive Diagnostic Drugs Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Radioactive Diagnostic Drugs Market Size and Forecast (2019-2030)
7.3.5 Russia Radioactive Diagnostic Drugs Market Size and Forecast (2019-2030)
7.3.6 Italy Radioactive Diagnostic Drugs Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Radioactive Diagnostic Drugs Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Radioactive Diagnostic Drugs Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Radioactive Diagnostic Drugs Market Size by Region
8.3.1 Asia-Pacific Radioactive Diagnostic Drugs Consumption Value by Region (2019-2030)
8.3.2 China Radioactive Diagnostic Drugs Market Size and Forecast (2019-2030)
8.3.3 Japan Radioactive Diagnostic Drugs Market Size and Forecast (2019-2030)
8.3.4 South Korea Radioactive Diagnostic Drugs Market Size and Forecast (2019-2030)
8.3.5 India Radioactive Diagnostic Drugs Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Radioactive Diagnostic Drugs Market Size and Forecast (2019-2030)
8.3.7 Australia Radioactive Diagnostic Drugs Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Radioactive Diagnostic Drugs Consumption Value by Type (2019-2030)
9.2 South America Radioactive Diagnostic Drugs Consumption Value by Application (2019-2030)
9.3 South America Radioactive Diagnostic Drugs Market Size by Country
9.3.1 South America Radioactive Diagnostic Drugs Consumption Value by Country (2019-2030)
9.3.2 Brazil Radioactive Diagnostic Drugs Market Size and Forecast (2019-2030)
9.3.3 Argentina Radioactive Diagnostic Drugs Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Radioactive Diagnostic Drugs Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Radioactive Diagnostic Drugs Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Radioactive Diagnostic Drugs Market Size by Country
10.3.1 Middle East & Africa Radioactive Diagnostic Drugs Consumption Value by Country (2019-2030)
10.3.2 Turkey Radioactive Diagnostic Drugs Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Radioactive Diagnostic Drugs Market Size and Forecast (2019-2030)
10.3.4 UAE Radioactive Diagnostic Drugs Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Radioactive Diagnostic Drugs Market Drivers
11.2 Radioactive Diagnostic Drugs Market Restraints
11.3 Radioactive Diagnostic Drugs Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Radioactive Diagnostic Drugs Industry Chain
12.2 Radioactive Diagnostic Drugs Upstream Analysis
12.3 Radioactive Diagnostic Drugs Midstream Analysis
12.4 Radioactive Diagnostic Drugs Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Radioactive Diagnostic Drugs
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Radioactive Diagnostic Drugs by Type
1.3.1 Overview: Global Radioactive Diagnostic Drugs Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Radioactive Diagnostic Drugs Consumption Value Market Share by Type in 2023
1.3.3 Single Photon Drugs
1.3.4 Positron Drugs
1.3.5 Blood Perfusion Drugs
1.3.6 Metabolizing Drugs
1.3.7 Receptor Binding Drugs
1.3.8 Others
1.4 Global Radioactive Diagnostic Drugs Market by Application
1.4.1 Overview: Global Radioactive Diagnostic Drugs Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Oncology
1.4.3 Cardiology
1.4.4 Neuroscience
1.4.5 Thyroid
1.4.6 Others
1.5 Global Radioactive Diagnostic Drugs Market Size & Forecast
1.6 Global Radioactive Diagnostic Drugs Market Size and Forecast by Region
1.6.1 Global Radioactive Diagnostic Drugs Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Radioactive Diagnostic Drugs Market Size by Region, (2019-2030)
1.6.3 North America Radioactive Diagnostic Drugs Market Size and Prospect (2019-2030)
1.6.4 Europe Radioactive Diagnostic Drugs Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Radioactive Diagnostic Drugs Market Size and Prospect (2019-2030)
1.6.6 South America Radioactive Diagnostic Drugs Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Radioactive Diagnostic Drugs Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Curium
2.1.1 Curium Details
2.1.2 Curium Major Business
2.1.3 Curium Radioactive Diagnostic Drugs Product and Solutions
2.1.4 Curium Radioactive Diagnostic Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Curium Recent Developments and Future Plans
2.2 Medi-Radiopharma
2.2.1 Medi-Radiopharma Details
2.2.2 Medi-Radiopharma Major Business
2.2.3 Medi-Radiopharma Radioactive Diagnostic Drugs Product and Solutions
2.2.4 Medi-Radiopharma Radioactive Diagnostic Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Medi-Radiopharma Recent Developments and Future Plans
2.3 Jubilant Radiopharma
2.3.1 Jubilant Radiopharma Details
2.3.2 Jubilant Radiopharma Major Business
2.3.3 Jubilant Radiopharma Radioactive Diagnostic Drugs Product and Solutions
2.3.4 Jubilant Radiopharma Radioactive Diagnostic Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Jubilant Radiopharma Recent Developments and Future Plans
2.4 Telix
2.4.1 Telix Details
2.4.2 Telix Major Business
2.4.3 Telix Radioactive Diagnostic Drugs Product and Solutions
2.4.4 Telix Radioactive Diagnostic Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Telix Recent Developments and Future Plans
2.5 Mallinckrodt
2.5.1 Mallinckrodt Details
2.5.2 Mallinckrodt Major Business
2.5.3 Mallinckrodt Radioactive Diagnostic Drugs Product and Solutions
2.5.4 Mallinckrodt Radioactive Diagnostic Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Mallinckrodt Recent Developments and Future Plans
2.6 Cardinal Health
2.6.1 Cardinal Health Details
2.6.2 Cardinal Health Major Business
2.6.3 Cardinal Health Radioactive Diagnostic Drugs Product and Solutions
2.6.4 Cardinal Health Radioactive Diagnostic Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Cardinal Health Recent Developments and Future Plans
2.7 Bayer AG
2.7.1 Bayer AG Details
2.7.2 Bayer AG Major Business
2.7.3 Bayer AG Radioactive Diagnostic Drugs Product and Solutions
2.7.4 Bayer AG Radioactive Diagnostic Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Bayer AG Recent Developments and Future Plans
2.8 GE Healthcare
2.8.1 GE Healthcare Details
2.8.2 GE Healthcare Major Business
2.8.3 GE Healthcare Radioactive Diagnostic Drugs Product and Solutions
2.8.4 GE Healthcare Radioactive Diagnostic Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 GE Healthcare Recent Developments and Future Plans
2.9 Mallinckrodt Pharmaceuticals
2.9.1 Mallinckrodt Pharmaceuticals Details
2.9.2 Mallinckrodt Pharmaceuticals Major Business
2.9.3 Mallinckrodt Pharmaceuticals Radioactive Diagnostic Drugs Product and Solutions
2.9.4 Mallinckrodt Pharmaceuticals Radioactive Diagnostic Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Mallinckrodt Pharmaceuticals Recent Developments and Future Plans
2.10 Bracco Group
2.10.1 Bracco Group Details
2.10.2 Bracco Group Major Business
2.10.3 Bracco Group Radioactive Diagnostic Drugs Product and Solutions
2.10.4 Bracco Group Radioactive Diagnostic Drugs Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Bracco Group Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Radioactive Diagnostic Drugs Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Radioactive Diagnostic Drugs by Company Revenue
3.2.2 Top 3 Radioactive Diagnostic Drugs Players Market Share in 2023
3.2.3 Top 6 Radioactive Diagnostic Drugs Players Market Share in 2023
3.3 Radioactive Diagnostic Drugs Market: Overall Company Footprint Analysis
3.3.1 Radioactive Diagnostic Drugs Market: Region Footprint
3.3.2 Radioactive Diagnostic Drugs Market: Company Product Type Footprint
3.3.3 Radioactive Diagnostic Drugs Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Radioactive Diagnostic Drugs Consumption Value and Market Share by Type (2019-2024)
4.2 Global Radioactive Diagnostic Drugs Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Radioactive Diagnostic Drugs Consumption Value Market Share by Application (2019-2024)
5.2 Global Radioactive Diagnostic Drugs Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Radioactive Diagnostic Drugs Consumption Value by Type (2019-2030)
6.2 North America Radioactive Diagnostic Drugs Consumption Value by Application (2019-2030)
6.3 North America Radioactive Diagnostic Drugs Market Size by Country
6.3.1 North America Radioactive Diagnostic Drugs Consumption Value by Country (2019-2030)
6.3.2 United States Radioactive Diagnostic Drugs Market Size and Forecast (2019-2030)
6.3.3 Canada Radioactive Diagnostic Drugs Market Size and Forecast (2019-2030)
6.3.4 Mexico Radioactive Diagnostic Drugs Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Radioactive Diagnostic Drugs Consumption Value by Type (2019-2030)
7.2 Europe Radioactive Diagnostic Drugs Consumption Value by Application (2019-2030)
7.3 Europe Radioactive Diagnostic Drugs Market Size by Country
7.3.1 Europe Radioactive Diagnostic Drugs Consumption Value by Country (2019-2030)
7.3.2 Germany Radioactive Diagnostic Drugs Market Size and Forecast (2019-2030)
7.3.3 France Radioactive Diagnostic Drugs Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Radioactive Diagnostic Drugs Market Size and Forecast (2019-2030)
7.3.5 Russia Radioactive Diagnostic Drugs Market Size and Forecast (2019-2030)
7.3.6 Italy Radioactive Diagnostic Drugs Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Radioactive Diagnostic Drugs Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Radioactive Diagnostic Drugs Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Radioactive Diagnostic Drugs Market Size by Region
8.3.1 Asia-Pacific Radioactive Diagnostic Drugs Consumption Value by Region (2019-2030)
8.3.2 China Radioactive Diagnostic Drugs Market Size and Forecast (2019-2030)
8.3.3 Japan Radioactive Diagnostic Drugs Market Size and Forecast (2019-2030)
8.3.4 South Korea Radioactive Diagnostic Drugs Market Size and Forecast (2019-2030)
8.3.5 India Radioactive Diagnostic Drugs Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Radioactive Diagnostic Drugs Market Size and Forecast (2019-2030)
8.3.7 Australia Radioactive Diagnostic Drugs Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Radioactive Diagnostic Drugs Consumption Value by Type (2019-2030)
9.2 South America Radioactive Diagnostic Drugs Consumption Value by Application (2019-2030)
9.3 South America Radioactive Diagnostic Drugs Market Size by Country
9.3.1 South America Radioactive Diagnostic Drugs Consumption Value by Country (2019-2030)
9.3.2 Brazil Radioactive Diagnostic Drugs Market Size and Forecast (2019-2030)
9.3.3 Argentina Radioactive Diagnostic Drugs Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Radioactive Diagnostic Drugs Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Radioactive Diagnostic Drugs Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Radioactive Diagnostic Drugs Market Size by Country
10.3.1 Middle East & Africa Radioactive Diagnostic Drugs Consumption Value by Country (2019-2030)
10.3.2 Turkey Radioactive Diagnostic Drugs Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Radioactive Diagnostic Drugs Market Size and Forecast (2019-2030)
10.3.4 UAE Radioactive Diagnostic Drugs Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Radioactive Diagnostic Drugs Market Drivers
11.2 Radioactive Diagnostic Drugs Market Restraints
11.3 Radioactive Diagnostic Drugs Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Radioactive Diagnostic Drugs Industry Chain
12.2 Radioactive Diagnostic Drugs Upstream Analysis
12.3 Radioactive Diagnostic Drugs Midstream Analysis
12.4 Radioactive Diagnostic Drugs Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
.
Table 1. Global Radioactive Diagnostic Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Radioactive Diagnostic Drugs Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Radioactive Diagnostic Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Radioactive Diagnostic Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Curium Company Information, Head Office, and Major Competitors
Table 6. Curium Major Business
Table 7. Curium Radioactive Diagnostic Drugs Product and Solutions
Table 8. Curium Radioactive Diagnostic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Curium Recent Developments and Future Plans
Table 10. Medi-Radiopharma Company Information, Head Office, and Major Competitors
Table 11. Medi-Radiopharma Major Business
Table 12. Medi-Radiopharma Radioactive Diagnostic Drugs Product and Solutions
Table 13. Medi-Radiopharma Radioactive Diagnostic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Medi-Radiopharma Recent Developments and Future Plans
Table 15. Jubilant Radiopharma Company Information, Head Office, and Major Competitors
Table 16. Jubilant Radiopharma Major Business
Table 17. Jubilant Radiopharma Radioactive Diagnostic Drugs Product and Solutions
Table 18. Jubilant Radiopharma Radioactive Diagnostic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Jubilant Radiopharma Recent Developments and Future Plans
Table 20. Telix Company Information, Head Office, and Major Competitors
Table 21. Telix Major Business
Table 22. Telix Radioactive Diagnostic Drugs Product and Solutions
Table 23. Telix Radioactive Diagnostic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Telix Recent Developments and Future Plans
Table 25. Mallinckrodt Company Information, Head Office, and Major Competitors
Table 26. Mallinckrodt Major Business
Table 27. Mallinckrodt Radioactive Diagnostic Drugs Product and Solutions
Table 28. Mallinckrodt Radioactive Diagnostic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Mallinckrodt Recent Developments and Future Plans
Table 30. Cardinal Health Company Information, Head Office, and Major Competitors
Table 31. Cardinal Health Major Business
Table 32. Cardinal Health Radioactive Diagnostic Drugs Product and Solutions
Table 33. Cardinal Health Radioactive Diagnostic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Cardinal Health Recent Developments and Future Plans
Table 35. Bayer AG Company Information, Head Office, and Major Competitors
Table 36. Bayer AG Major Business
Table 37. Bayer AG Radioactive Diagnostic Drugs Product and Solutions
Table 38. Bayer AG Radioactive Diagnostic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Bayer AG Recent Developments and Future Plans
Table 40. GE Healthcare Company Information, Head Office, and Major Competitors
Table 41. GE Healthcare Major Business
Table 42. GE Healthcare Radioactive Diagnostic Drugs Product and Solutions
Table 43. GE Healthcare Radioactive Diagnostic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. GE Healthcare Recent Developments and Future Plans
Table 45. Mallinckrodt Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 46. Mallinckrodt Pharmaceuticals Major Business
Table 47. Mallinckrodt Pharmaceuticals Radioactive Diagnostic Drugs Product and Solutions
Table 48. Mallinckrodt Pharmaceuticals Radioactive Diagnostic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Mallinckrodt Pharmaceuticals Recent Developments and Future Plans
Table 50. Bracco Group Company Information, Head Office, and Major Competitors
Table 51. Bracco Group Major Business
Table 52. Bracco Group Radioactive Diagnostic Drugs Product and Solutions
Table 53. Bracco Group Radioactive Diagnostic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Bracco Group Recent Developments and Future Plans
Table 55. Global Radioactive Diagnostic Drugs Revenue (USD Million) by Players (2019-2024)
Table 56. Global Radioactive Diagnostic Drugs Revenue Share by Players (2019-2024)
Table 57. Breakdown of Radioactive Diagnostic Drugs by Company Type (Tier 1, Tier 2, and Tier 3)
Table 58. Market Position of Players in Radioactive Diagnostic Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 59. Head Office of Key Radioactive Diagnostic Drugs Players
Table 60. Radioactive Diagnostic Drugs Market: Company Product Type Footprint
Table 61. Radioactive Diagnostic Drugs Market: Company Product Application Footprint
Table 62. Radioactive Diagnostic Drugs New Market Entrants and Barriers to Market Entry
Table 63. Radioactive Diagnostic Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 64. Global Radioactive Diagnostic Drugs Consumption Value (USD Million) by Type (2019-2024)
Table 65. Global Radioactive Diagnostic Drugs Consumption Value Share by Type (2019-2024)
Table 66. Global Radioactive Diagnostic Drugs Consumption Value Forecast by Type (2025-2030)
Table 67. Global Radioactive Diagnostic Drugs Consumption Value by Application (2019-2024)
Table 68. Global Radioactive Diagnostic Drugs Consumption Value Forecast by Application (2025-2030)
Table 69. North America Radioactive Diagnostic Drugs Consumption Value by Type (2019-2024) & (USD Million)
Table 70. North America Radioactive Diagnostic Drugs Consumption Value by Type (2025-2030) & (USD Million)
Table 71. North America Radioactive Diagnostic Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 72. North America Radioactive Diagnostic Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 73. North America Radioactive Diagnostic Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 74. North America Radioactive Diagnostic Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 75. Europe Radioactive Diagnostic Drugs Consumption Value by Type (2019-2024) & (USD Million)
Table 76. Europe Radioactive Diagnostic Drugs Consumption Value by Type (2025-2030) & (USD Million)
Table 77. Europe Radioactive Diagnostic Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 78. Europe Radioactive Diagnostic Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 79. Europe Radioactive Diagnostic Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 80. Europe Radioactive Diagnostic Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 81. Asia-Pacific Radioactive Diagnostic Drugs Consumption Value by Type (2019-2024) & (USD Million)
Table 82. Asia-Pacific Radioactive Diagnostic Drugs Consumption Value by Type (2025-2030) & (USD Million)
Table 83. Asia-Pacific Radioactive Diagnostic Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 84. Asia-Pacific Radioactive Diagnostic Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 85. Asia-Pacific Radioactive Diagnostic Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 86. Asia-Pacific Radioactive Diagnostic Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 87. South America Radioactive Diagnostic Drugs Consumption Value by Type (2019-2024) & (USD Million)
Table 88. South America Radioactive Diagnostic Drugs Consumption Value by Type (2025-2030) & (USD Million)
Table 89. South America Radioactive Diagnostic Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 90. South America Radioactive Diagnostic Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 91. South America Radioactive Diagnostic Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 92. South America Radioactive Diagnostic Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 93. Middle East & Africa Radioactive Diagnostic Drugs Consumption Value by Type (2019-2024) & (USD Million)
Table 94. Middle East & Africa Radioactive Diagnostic Drugs Consumption Value by Type (2025-2030) & (USD Million)
Table 95. Middle East & Africa Radioactive Diagnostic Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 96. Middle East & Africa Radioactive Diagnostic Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 97. Middle East & Africa Radioactive Diagnostic Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 98. Middle East & Africa Radioactive Diagnostic Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 99. Radioactive Diagnostic Drugs Raw Material
Table 100. Key Suppliers of Radioactive Diagnostic Drugs Raw Materials
LIST OF FIGURE
. s
Figure 1. Radioactive Diagnostic Drugs Picture
Figure 2. Global Radioactive Diagnostic Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Radioactive Diagnostic Drugs Consumption Value Market Share by Type in 2023
Figure 4. Single Photon Drugs
Figure 5. Positron Drugs
Figure 6. Blood Perfusion Drugs
Figure 7. Metabolizing Drugs
Figure 8. Receptor Binding Drugs
Figure 9. Others
Figure 10. Global Radioactive Diagnostic Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 11. Radioactive Diagnostic Drugs Consumption Value Market Share by Application in 2023
Figure 12. Oncology Picture
Figure 13. Cardiology Picture
Figure 14. Neuroscience Picture
Figure 15. Thyroid Picture
Figure 16. Others Picture
Figure 17. Global Radioactive Diagnostic Drugs Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 18. Global Radioactive Diagnostic Drugs Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 19. Global Market Radioactive Diagnostic Drugs Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 20. Global Radioactive Diagnostic Drugs Consumption Value Market Share by Region (2019-2030)
Figure 21. Global Radioactive Diagnostic Drugs Consumption Value Market Share by Region in 2023
Figure 22. North America Radioactive Diagnostic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 23. Europe Radioactive Diagnostic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 24. Asia-Pacific Radioactive Diagnostic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 25. South America Radioactive Diagnostic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 26. Middle East and Africa Radioactive Diagnostic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 27. Global Radioactive Diagnostic Drugs Revenue Share by Players in 2023
Figure 28. Radioactive Diagnostic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 29. Global Top 3 Players Radioactive Diagnostic Drugs Market Share in 2023
Figure 30. Global Top 6 Players Radioactive Diagnostic Drugs Market Share in 2023
Figure 31. Global Radioactive Diagnostic Drugs Consumption Value Share by Type (2019-2024)
Figure 32. Global Radioactive Diagnostic Drugs Market Share Forecast by Type (2025-2030)
Figure 33. Global Radioactive Diagnostic Drugs Consumption Value Share by Application (2019-2024)
Figure 34. Global Radioactive Diagnostic Drugs Market Share Forecast by Application (2025-2030)
Figure 35. North America Radioactive Diagnostic Drugs Consumption Value Market Share by Type (2019-2030)
Figure 36. North America Radioactive Diagnostic Drugs Consumption Value Market Share by Application (2019-2030)
Figure 37. North America Radioactive Diagnostic Drugs Consumption Value Market Share by Country (2019-2030)
Figure 38. United States Radioactive Diagnostic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 39. Canada Radioactive Diagnostic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 40. Mexico Radioactive Diagnostic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 41. Europe Radioactive Diagnostic Drugs Consumption Value Market Share by Type (2019-2030)
Figure 42. Europe Radioactive Diagnostic Drugs Consumption Value Market Share by Application (2019-2030)
Figure 43. Europe Radioactive Diagnostic Drugs Consumption Value Market Share by Country (2019-2030)
Figure 44. Germany Radioactive Diagnostic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 45. France Radioactive Diagnostic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 46. United Kingdom Radioactive Diagnostic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 47. Russia Radioactive Diagnostic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 48. Italy Radioactive Diagnostic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 49. Asia-Pacific Radioactive Diagnostic Drugs Consumption Value Market Share by Type (2019-2030)
Figure 50. Asia-Pacific Radioactive Diagnostic Drugs Consumption Value Market Share by Application (2019-2030)
Figure 51. Asia-Pacific Radioactive Diagnostic Drugs Consumption Value Market Share by Region (2019-2030)
Figure 52. China Radioactive Diagnostic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 53. Japan Radioactive Diagnostic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 54. South Korea Radioactive Diagnostic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 55. India Radioactive Diagnostic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 56. Southeast Asia Radioactive Diagnostic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 57. Australia Radioactive Diagnostic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 58. South America Radioactive Diagnostic Drugs Consumption Value Market Share by Type (2019-2030)
Figure 59. South America Radioactive Diagnostic Drugs Consumption Value Market Share by Application (2019-2030)
Figure 60. South America Radioactive Diagnostic Drugs Consumption Value Market Share by Country (2019-2030)
Figure 61. Brazil Radioactive Diagnostic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 62. Argentina Radioactive Diagnostic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 63. Middle East and Africa Radioactive Diagnostic Drugs Consumption Value Market Share by Type (2019-2030)
Figure 64. Middle East and Africa Radioactive Diagnostic Drugs Consumption Value Market Share by Application (2019-2030)
Figure 65. Middle East and Africa Radioactive Diagnostic Drugs Consumption Value Market Share by Country (2019-2030)
Figure 66. Turkey Radioactive Diagnostic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 67. Saudi Arabia Radioactive Diagnostic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 68. UAE Radioactive Diagnostic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 69. Radioactive Diagnostic Drugs Market Drivers
Figure 70. Radioactive Diagnostic Drugs Market Restraints
Figure 71. Radioactive Diagnostic Drugs Market Trends
Figure 72. Porters Five Forces Analysis
Figure 73. Manufacturing Cost Structure Analysis of Radioactive Diagnostic Drugs in 2023
Figure 74. Manufacturing Process Analysis of Radioactive Diagnostic Drugs
Figure 75. Radioactive Diagnostic Drugs Industrial Chain
Figure 76. Methodology
Figure 77. Research Process and Data Source
.
Table 1. Global Radioactive Diagnostic Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Radioactive Diagnostic Drugs Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Radioactive Diagnostic Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Radioactive Diagnostic Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Curium Company Information, Head Office, and Major Competitors
Table 6. Curium Major Business
Table 7. Curium Radioactive Diagnostic Drugs Product and Solutions
Table 8. Curium Radioactive Diagnostic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Curium Recent Developments and Future Plans
Table 10. Medi-Radiopharma Company Information, Head Office, and Major Competitors
Table 11. Medi-Radiopharma Major Business
Table 12. Medi-Radiopharma Radioactive Diagnostic Drugs Product and Solutions
Table 13. Medi-Radiopharma Radioactive Diagnostic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Medi-Radiopharma Recent Developments and Future Plans
Table 15. Jubilant Radiopharma Company Information, Head Office, and Major Competitors
Table 16. Jubilant Radiopharma Major Business
Table 17. Jubilant Radiopharma Radioactive Diagnostic Drugs Product and Solutions
Table 18. Jubilant Radiopharma Radioactive Diagnostic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Jubilant Radiopharma Recent Developments and Future Plans
Table 20. Telix Company Information, Head Office, and Major Competitors
Table 21. Telix Major Business
Table 22. Telix Radioactive Diagnostic Drugs Product and Solutions
Table 23. Telix Radioactive Diagnostic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Telix Recent Developments and Future Plans
Table 25. Mallinckrodt Company Information, Head Office, and Major Competitors
Table 26. Mallinckrodt Major Business
Table 27. Mallinckrodt Radioactive Diagnostic Drugs Product and Solutions
Table 28. Mallinckrodt Radioactive Diagnostic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Mallinckrodt Recent Developments and Future Plans
Table 30. Cardinal Health Company Information, Head Office, and Major Competitors
Table 31. Cardinal Health Major Business
Table 32. Cardinal Health Radioactive Diagnostic Drugs Product and Solutions
Table 33. Cardinal Health Radioactive Diagnostic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Cardinal Health Recent Developments and Future Plans
Table 35. Bayer AG Company Information, Head Office, and Major Competitors
Table 36. Bayer AG Major Business
Table 37. Bayer AG Radioactive Diagnostic Drugs Product and Solutions
Table 38. Bayer AG Radioactive Diagnostic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Bayer AG Recent Developments and Future Plans
Table 40. GE Healthcare Company Information, Head Office, and Major Competitors
Table 41. GE Healthcare Major Business
Table 42. GE Healthcare Radioactive Diagnostic Drugs Product and Solutions
Table 43. GE Healthcare Radioactive Diagnostic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. GE Healthcare Recent Developments and Future Plans
Table 45. Mallinckrodt Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 46. Mallinckrodt Pharmaceuticals Major Business
Table 47. Mallinckrodt Pharmaceuticals Radioactive Diagnostic Drugs Product and Solutions
Table 48. Mallinckrodt Pharmaceuticals Radioactive Diagnostic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Mallinckrodt Pharmaceuticals Recent Developments and Future Plans
Table 50. Bracco Group Company Information, Head Office, and Major Competitors
Table 51. Bracco Group Major Business
Table 52. Bracco Group Radioactive Diagnostic Drugs Product and Solutions
Table 53. Bracco Group Radioactive Diagnostic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Bracco Group Recent Developments and Future Plans
Table 55. Global Radioactive Diagnostic Drugs Revenue (USD Million) by Players (2019-2024)
Table 56. Global Radioactive Diagnostic Drugs Revenue Share by Players (2019-2024)
Table 57. Breakdown of Radioactive Diagnostic Drugs by Company Type (Tier 1, Tier 2, and Tier 3)
Table 58. Market Position of Players in Radioactive Diagnostic Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 59. Head Office of Key Radioactive Diagnostic Drugs Players
Table 60. Radioactive Diagnostic Drugs Market: Company Product Type Footprint
Table 61. Radioactive Diagnostic Drugs Market: Company Product Application Footprint
Table 62. Radioactive Diagnostic Drugs New Market Entrants and Barriers to Market Entry
Table 63. Radioactive Diagnostic Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 64. Global Radioactive Diagnostic Drugs Consumption Value (USD Million) by Type (2019-2024)
Table 65. Global Radioactive Diagnostic Drugs Consumption Value Share by Type (2019-2024)
Table 66. Global Radioactive Diagnostic Drugs Consumption Value Forecast by Type (2025-2030)
Table 67. Global Radioactive Diagnostic Drugs Consumption Value by Application (2019-2024)
Table 68. Global Radioactive Diagnostic Drugs Consumption Value Forecast by Application (2025-2030)
Table 69. North America Radioactive Diagnostic Drugs Consumption Value by Type (2019-2024) & (USD Million)
Table 70. North America Radioactive Diagnostic Drugs Consumption Value by Type (2025-2030) & (USD Million)
Table 71. North America Radioactive Diagnostic Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 72. North America Radioactive Diagnostic Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 73. North America Radioactive Diagnostic Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 74. North America Radioactive Diagnostic Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 75. Europe Radioactive Diagnostic Drugs Consumption Value by Type (2019-2024) & (USD Million)
Table 76. Europe Radioactive Diagnostic Drugs Consumption Value by Type (2025-2030) & (USD Million)
Table 77. Europe Radioactive Diagnostic Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 78. Europe Radioactive Diagnostic Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 79. Europe Radioactive Diagnostic Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 80. Europe Radioactive Diagnostic Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 81. Asia-Pacific Radioactive Diagnostic Drugs Consumption Value by Type (2019-2024) & (USD Million)
Table 82. Asia-Pacific Radioactive Diagnostic Drugs Consumption Value by Type (2025-2030) & (USD Million)
Table 83. Asia-Pacific Radioactive Diagnostic Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 84. Asia-Pacific Radioactive Diagnostic Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 85. Asia-Pacific Radioactive Diagnostic Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 86. Asia-Pacific Radioactive Diagnostic Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 87. South America Radioactive Diagnostic Drugs Consumption Value by Type (2019-2024) & (USD Million)
Table 88. South America Radioactive Diagnostic Drugs Consumption Value by Type (2025-2030) & (USD Million)
Table 89. South America Radioactive Diagnostic Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 90. South America Radioactive Diagnostic Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 91. South America Radioactive Diagnostic Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 92. South America Radioactive Diagnostic Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 93. Middle East & Africa Radioactive Diagnostic Drugs Consumption Value by Type (2019-2024) & (USD Million)
Table 94. Middle East & Africa Radioactive Diagnostic Drugs Consumption Value by Type (2025-2030) & (USD Million)
Table 95. Middle East & Africa Radioactive Diagnostic Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 96. Middle East & Africa Radioactive Diagnostic Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 97. Middle East & Africa Radioactive Diagnostic Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 98. Middle East & Africa Radioactive Diagnostic Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 99. Radioactive Diagnostic Drugs Raw Material
Table 100. Key Suppliers of Radioactive Diagnostic Drugs Raw Materials
LIST OF FIGURE
. s
Figure 1. Radioactive Diagnostic Drugs Picture
Figure 2. Global Radioactive Diagnostic Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Radioactive Diagnostic Drugs Consumption Value Market Share by Type in 2023
Figure 4. Single Photon Drugs
Figure 5. Positron Drugs
Figure 6. Blood Perfusion Drugs
Figure 7. Metabolizing Drugs
Figure 8. Receptor Binding Drugs
Figure 9. Others
Figure 10. Global Radioactive Diagnostic Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 11. Radioactive Diagnostic Drugs Consumption Value Market Share by Application in 2023
Figure 12. Oncology Picture
Figure 13. Cardiology Picture
Figure 14. Neuroscience Picture
Figure 15. Thyroid Picture
Figure 16. Others Picture
Figure 17. Global Radioactive Diagnostic Drugs Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 18. Global Radioactive Diagnostic Drugs Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 19. Global Market Radioactive Diagnostic Drugs Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 20. Global Radioactive Diagnostic Drugs Consumption Value Market Share by Region (2019-2030)
Figure 21. Global Radioactive Diagnostic Drugs Consumption Value Market Share by Region in 2023
Figure 22. North America Radioactive Diagnostic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 23. Europe Radioactive Diagnostic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 24. Asia-Pacific Radioactive Diagnostic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 25. South America Radioactive Diagnostic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 26. Middle East and Africa Radioactive Diagnostic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 27. Global Radioactive Diagnostic Drugs Revenue Share by Players in 2023
Figure 28. Radioactive Diagnostic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 29. Global Top 3 Players Radioactive Diagnostic Drugs Market Share in 2023
Figure 30. Global Top 6 Players Radioactive Diagnostic Drugs Market Share in 2023
Figure 31. Global Radioactive Diagnostic Drugs Consumption Value Share by Type (2019-2024)
Figure 32. Global Radioactive Diagnostic Drugs Market Share Forecast by Type (2025-2030)
Figure 33. Global Radioactive Diagnostic Drugs Consumption Value Share by Application (2019-2024)
Figure 34. Global Radioactive Diagnostic Drugs Market Share Forecast by Application (2025-2030)
Figure 35. North America Radioactive Diagnostic Drugs Consumption Value Market Share by Type (2019-2030)
Figure 36. North America Radioactive Diagnostic Drugs Consumption Value Market Share by Application (2019-2030)
Figure 37. North America Radioactive Diagnostic Drugs Consumption Value Market Share by Country (2019-2030)
Figure 38. United States Radioactive Diagnostic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 39. Canada Radioactive Diagnostic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 40. Mexico Radioactive Diagnostic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 41. Europe Radioactive Diagnostic Drugs Consumption Value Market Share by Type (2019-2030)
Figure 42. Europe Radioactive Diagnostic Drugs Consumption Value Market Share by Application (2019-2030)
Figure 43. Europe Radioactive Diagnostic Drugs Consumption Value Market Share by Country (2019-2030)
Figure 44. Germany Radioactive Diagnostic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 45. France Radioactive Diagnostic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 46. United Kingdom Radioactive Diagnostic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 47. Russia Radioactive Diagnostic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 48. Italy Radioactive Diagnostic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 49. Asia-Pacific Radioactive Diagnostic Drugs Consumption Value Market Share by Type (2019-2030)
Figure 50. Asia-Pacific Radioactive Diagnostic Drugs Consumption Value Market Share by Application (2019-2030)
Figure 51. Asia-Pacific Radioactive Diagnostic Drugs Consumption Value Market Share by Region (2019-2030)
Figure 52. China Radioactive Diagnostic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 53. Japan Radioactive Diagnostic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 54. South Korea Radioactive Diagnostic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 55. India Radioactive Diagnostic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 56. Southeast Asia Radioactive Diagnostic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 57. Australia Radioactive Diagnostic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 58. South America Radioactive Diagnostic Drugs Consumption Value Market Share by Type (2019-2030)
Figure 59. South America Radioactive Diagnostic Drugs Consumption Value Market Share by Application (2019-2030)
Figure 60. South America Radioactive Diagnostic Drugs Consumption Value Market Share by Country (2019-2030)
Figure 61. Brazil Radioactive Diagnostic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 62. Argentina Radioactive Diagnostic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 63. Middle East and Africa Radioactive Diagnostic Drugs Consumption Value Market Share by Type (2019-2030)
Figure 64. Middle East and Africa Radioactive Diagnostic Drugs Consumption Value Market Share by Application (2019-2030)
Figure 65. Middle East and Africa Radioactive Diagnostic Drugs Consumption Value Market Share by Country (2019-2030)
Figure 66. Turkey Radioactive Diagnostic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 67. Saudi Arabia Radioactive Diagnostic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 68. UAE Radioactive Diagnostic Drugs Consumption Value (2019-2030) & (USD Million)
Figure 69. Radioactive Diagnostic Drugs Market Drivers
Figure 70. Radioactive Diagnostic Drugs Market Restraints
Figure 71. Radioactive Diagnostic Drugs Market Trends
Figure 72. Porters Five Forces Analysis
Figure 73. Manufacturing Cost Structure Analysis of Radioactive Diagnostic Drugs in 2023
Figure 74. Manufacturing Process Analysis of Radioactive Diagnostic Drugs
Figure 75. Radioactive Diagnostic Drugs Industrial Chain
Figure 76. Methodology
Figure 77. Research Process and Data Source
